Research / Publications

Doxepin withdrawal mania.

Galynker II, Rosenthal RN, Perkel C, Shwartz A.

J Clin Psychiatry. 1995 Mar;56(3):122-3. 

PMID: 7883732

A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal.

Rosenthal RN, Perkel C, Singh P, Anand O, Miner CR.

Am J Addict. 1998 Summer;7(3):189-97.

PMID: 9702286

Cannabis - the debate continues: a South African perspective: original article

Perkel C.

South African Psychiatry Review Vol.8(1) 2005: 25-30.

Medical management of opioid dependence in South Africa.

Weich L, Perkel C, van Zyl N, Rataemane ST, Naidoo L.

S Afr Med J. 2008 Apr;98(4):280-3. Review.

PMID: 18637636

South African guidelines for the management of opioid dependence: updated 2009.

Weich L, Perkel C, van Zyl N, Rataemane, Naidoo L.

S Afr Med J. 2010 Jan;100(1):1-18. Review. 

PMID: 20429474

Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.

Bassir Nia A, Medrano B, Perkel C, Galynker I, Hurd YL.

J Psychopharmacol. 2016 Dec;30(12):1321-1330. 

PMID: 27462088

Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System.

Coplan PM, Sessler NE, Harikrishnan V, Singh R, Perkel C.

Postgrad Med. 2017 Jan;129(1):55-61. 

PMID: 27922764

The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population.

Bassir Nia, Mann CL, Spriggs S, DeFrancisco DR, Carbonaro S, Parvez L, Galynker II, Perkel CA, Hurd YL.

J Clin Psychiatry. 2019 Jul 2;80(4).

PMID: 31265768

Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity.

Gibson CL, Bassir Nia A, Spriggs SA, DeFrancisco D, Swift A, Perkel C, Zhong X, Mazumdar M, Fernandez N, Patel M, Kim-Schulze S, Hurd YL.

Psychiatry Res. 2020 Aug 10;293:113380.

PMID: 32818918